The time is now to align on a shared plan of action as a country to achieve diversity, equity, inclusion, and access in US ...

The University of Birmingham’s Cancer Research UK Clinical Trials Unit is leading a new trial to improve outcomes for ...

Scientists at the Johns Hopkins Kimmel Cancer Center have identified 16 genes that breast cancer cells use to survive in the bloodstream after they've escaped the low-oxygen regions of a tumor. Each ...

Ichnos Glenmark Innovation's cancer drug ISB 2001 shows promising results in Phase 1 trial, to be presented at ASH.

Healthcare: Cancer is a heterogeneous and multifactorial disease. Among multiple factors, it may be caused by errors, or mutations, within our genes – the blueprint that dictate how our cells function ...

In a tough fundraising space, cell therapy biotechs pursuing autoimmune indications review staffing to ensure the right ...

Scientists and clinicians at the University of Leeds exploring new radiotherapy treatments and technologies have been given a ...

The method employs ultrathin membranes to capture small packets of cellular material known as extracellular vesicles. Cells ...

Treatment for rectal cancer may differ from that of colon cancer because of the increased risk of recurrence and poorer ...

Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), today announced the appointment of Claudia Lopez, DVM, MSc, as its new Vice President, Clinical Product Development. Dr. Lopez ...